Neurobehavioral effects of treatment for opiate withdrawal: Figure 1
Authors:
Open Access
- 21 December 2004
- journal article
- clinical trial
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
- Vol. 90 (1) , F73-F74
Abstract
A partially randomised, controlled trial was performed to test the hypothesis that opiate exposed infants treated with diluted tincture of opium (DTO) and phenobarbital would have better neurobehavioral scores than infants treated with DTO alone. Compared with those treated with DTO alone (n = 15), infants treated with DTO and phenobarbital (n = 17) were more interactive, had smoother movements, were easier to handle, and less stressed. Dual treatment results in improved neurobehavioral organisation during the first three weeks of life, which may indicate a more rapid recovery from opiate withdrawal.Keywords
This publication has 7 references indexed in Scilit:
- NICU Network Neurobehavioral Scale™2004
- Diluted tincture of opium (DTO) and phenobarbital versus DTO alone for neonatal opiate withdrawal in term infantsThe Journal of Pediatrics, 2002
- Early Development of Infants Exposed to Drugs PrenatallyClinics in Perinatology, 1999
- Fetal EffectsNeurologic Clinics, 1993
- Improving treatment outcome in pregnant opiate-dependent womenJournal of Substance Abuse Treatment, 1992
- No Adjustments Are Needed for Multiple ComparisonsEpidemiology, 1990
- Neonatal behavior after drug dependent pregnancy.Archives of Disease in Childhood, 1989